Key Takeaways
- Starting Jan. 1, 2027, new CMS policies limit RTM services to established patients, requiring practitioners who report RPM or RTM services to furnish a separately reportable initiating visit at the onset of services. They also revise the valuation of RPM and RTM services under the PFS, specifically reducing payment for device supply and setup codes, with many reductions phased in over multiple years.
- Beginning Jan. 1, 2029, Medicare will pay for RPM and RTM services only when they are performed by clinical staff who are “direct employees” of the billing practice, and not when those services are delivered by third-party contractors.
- Providers should use the two-year transition period to evaluate staffing models, vendor arrangements and related contracts, including whether to bring clinical staff in-house or restructure existing relationships before the requirement takes effect.
On Nov. 4, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the 2027 Medicare Physician Fee Schedule (PFS) final rule (published in the Federal Register on Nov. 9, 2026), which will have significant implications for remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) services. The headline for many providers is that beginning Jan. 1, 2029, CMS will pay for RPM and RTM services rendered by clinical staff only when those staff are direct employees of the billing practitioner or practice. This change is designed to curb a common outsourced staffing model. Although practices may continue to use contracted clinical staff for two more years, CMS cautioned that RPM and RTM services remain subject to billing rules and require adequate oversight and clinical integration. For both providers and digital health companies, the rule redraws the Medicare remote monitoring market.
Changes to Remote Monitoring Services
Changes starting Jan. 1, 2027. CMS finalized three remote monitoring policies: (1) limiting RTM services to established patients; (2) requiring practitioners who report RPM or RTM services to furnish a separately reportable initiating visit at the onset of services (although CMS clarified the visit need not be separately billable in every scenario, such as during a global surgical period); and (3) revising the valuation of RPM and RTM services under the PFS, specifically reducing payment for device supply and setup codes, with many reductions phased in over multiple years. The initiating visit may be furnished in person or via telehealth and need not be devoted solely to remote monitoring, but remote monitoring must be discussed. Beneficiaries already receiving RPM or RTM before Jan. 1, 2027, do not need a new initiating visit to continue services, provided all other requirements are met. Practices relying on telehealth for initiating visits should note that current Medicare telehealth flexibilities are scheduled to expire Dec. 31, 2027, absent congressional action.
Medicare to limit payment for contractor-delivered remote monitoring. Beginning Jan. 1, 2029, Medicare will pay for RPM and RTM services only when they are performed by clinical staff who are “direct employees” of the billing practice, and not when those services are delivered by third-party contractors. CMS first proposed the restriction for 2027 but, after public comment, delayed it two years to give practices time to adapt. Contracted clinical staffing remains permissible through Dec. 31, 2028, subject to “incident to” and other billing rules. CMS did not define “direct employee” or clarify whether certain alternative staffing arrangements would qualify, despite comments raising concerns about complex employment and staffing structures, including those used by health systems, academic medical centers and faculty practice plans. CMS indicated that it will issue sub-regulatory guidance clarifying permissible clinical staffing arrangements before Jan. 1, 2029. Practices and other providers that rely on outside monitoring companies or clinical staffing arrangements that may not satisfy the direct-employment requirement should use the transition period to review their staffing models and vendor contracts, evaluate potential restructuring options, and monitor CMS guidance before the requirement takes effect.
What CMS did not change. CMS declined to finalize its proposal to remove clinical staff practice expense from the RPM and RTM treatment management codes. CMS acknowledged that clinical staff are commonly used for this work, and CMS did not adopt the proposed consolidation of existing remote monitoring codes into four G-codes. CMS also confirmed that practices may continue to obtain devices, software, connectivity, data hosting, cybersecurity, implementation support, technical assistance and interoperability services from outside vendors, so long as those vendors do not supply clinical staff time. Clinical staff need not be physically located within the practice location, and time spent under the billing practitioner’s general supervision continues to count when all other “incident to” requirements are met.
Increased Scrutiny of Remote Monitoring
The final rule’s RPM and RTM changes follow years of scrutiny by the U.S. Department of Health and Human Services Office of Inspector General (OIG). OIG reported in September 2024 that 43% of enrollees receiving RPM did not receive all three required components of the service; for about 44% of enrollees, Medicare lacked information about who ordered the services; and CMS had no systematic way to identify the companies that offer RPM in conjunction with practices. OIG asked CMS to add safeguards, require additional claim information, and identify and monitor companies that bill for RPM.
OIG’s attention has since intensified. As discussed in September 2025, OIG found that Medicare RPM payments increased 31% from 2023 to 2024 and that nearly 1 million enrollees received RPM services. OIG also identified billing patterns that warranted “further scrutiny,” including sharp spikes in new enrollees, billing for patients with whom the practice had no prior medical relationship, and billing for enrollees who never received treatment management. The final rule and its focus on who furnishes monitoring services directly to beneficiaries suggest that CMS is acting on OIG’s concerns. CMS also stated that it observed troubling trends that align with, and sometimes go beyond, what OIG cited. CMS added that its program integrity concerns apply to RTM as well as RPM, noting that RTM codes are newer and have not been subject to audits as RPM codes have.
Next Steps for Providers and Operators
For Providers and Practices
- Enhance intake before 2027. Before Jan. 1, 2027, update intake and scheduling workflows so that, unless an exception applies, RPM or RTM services for each new beneficiary begin with a separately reportable initiating visit, and confirm that RTM services are furnished only to established patients.
- Evaluate RPM and RTM before 2029. Use the two-year transition period to evaluate staffing models, vendor arrangements and related contracts, including whether to bring clinical staff in-house or restructure existing relationships before the requirement takes effect. Monitor CMS’ sub-regulatory guidance on permissible staffing arrangements.
- Audit RPM and RTM billing. Given OIG’s focus, audit current RPM and RTM billing to confirm that each required component of the service is furnished and documented, that devices meet the definition of a medical device, and that reporting and billing policies are in place.
For Digital Health Companies and Vendors
The final rule’s staffing restriction targets who performs clinical monitoring work, not the technology that makes it possible. Although the restriction on vendor-delivered clinical services may significantly affect current arrangements, the two-year transition period is a window for remote monitoring companies to reassess their business models. The rule creates meaningful opportunities to try new ideas, including:
- Enabling in-house programs. As practices bring monitoring staff in-house, many will need workflow, triage, documentation and analytics tools that let a smaller employed team manage larger patient panels efficiently. Because CMS retained the practice expense inputs for treatment management codes, technology that supports clinical work remains tied to a reimbursable service.
- Initiating visit and enrollment support. Platforms that integrate telehealth scheduling, consent capture, eligibility tracking and documentation of the initiating visit can help practices meet the new requirements.
- Compliance as a differentiator. Given OIG’s focus on missing service components and unclear ordering relationships, technology that documents each required element and supports audit-ready records can become a selling point with practices and health systems.
- Restructuring and transactions. Companies with clinical service lines may consider transitioning to technology and nonclinical support service models, licensing arrangements, management service structures, joint ventures, or combinations of practices and health systems positioned to furnish these services directly. Any such structure should be reviewed under the Anti-Kickback Statute, Stark Law, state corporate practice of medicine and fee-splitting laws, and privacy laws.
- Value-based payment arrangements. Digital health companies may explore opportunities to support providers in Medicare value-based arrangements, including Medicare Shared Savings Program ACOs and Medicare Advantage risk-based contracts, or, if eligible, participate in CMS’ ACCESS Model for technology-supported chronic care. These arrangements may offer ways to demonstrate value through improved clinical outcomes and reduced costs, but they do not displace the new PFS rules: ACO participation does not exempt PFS-billed RPM or RTM services from the new requirements, and ACCESS participants generally may not also bill fee-for-service for aligned beneficiaries.
Looking Ahead
Remote monitoring remains a valuable tool for delivering ongoing care and being paid for it, but the calendar year (CY) 2027 PFS final rule and OIG’s continuing oversight make clear that program design and billing integrity will continue to be closely examined. For digital health companies, the next two years are a window to reposition from technology partners to practices that will own the clinical relationship, a role consistent with the final rule’s continued allowance of third-party technology supports. For more information about how the CY 2027 PFS final rule affects an RPM or RTM program or company, or about RPM billing, compliance, audits, or investigations, contact one of the authors or a member of the McGuireWoods Healthcare Compliance, Regulatory & Policy Practice Group.